Malignant Salivary Gland Neoplasm — Trials

Malignant Salivary Gland Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 63
Recruiting: 32
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 21.4%
Trials / 1,000 deaths: 56.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05553782	Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers	recruiting	Early Phase 1	30	Brigham and Women's HospitalOTHER	1	Jan 26, 2026	clinicaltrials
NCT01821612	Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer	completed	Early Phase 1	23	Alliance for Clinical Trials in OncologyOTHER	1	Jan 13, 2025	clinicaltrials